Patents by Inventor Eugene Skrabut

Eugene Skrabut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable hyaluronan/steroid formulation
    Patent number: 8680073
    Abstract: A pharmaceutical composition comprising in admixture a hyaluronic acid related component (HARC) and a pharmaceutically effective amount of triamcinolone hexacetonide (TAH). The composition is stable in an accelerated shelf life test in which the composition is heated to 80° C. for 24 hours.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: March 25, 2014
    Assignee: Genzyme Corporation
    Inventors: Grace Chang, Elizabeth Voschin, Li-Ping Yu, Eugene Skrabut
  • Stable Hyaluronan/Steroid Formulation
    Publication number: 20120316131
    Abstract: A pharmaceutical composition comprising in admixture a hyaluronic acid related component (HARC) and a pharmaceutically effective amount of triamcinolone hexacetonide (TAH). The composition is stable in an accelerated shelf life test in which the composition is heated to 80° C. for 24 hours.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 13, 2012
    Inventors: Grace Chang, Elizabeth Voschin, Li-Ping Yu, Eugene Skrabut
  • Stable hyaluronan/steroid formulation
    Patent number: 8273725
    Abstract: A pharmaceutical composition comprising in admixture a hyaluronic acid related component (HARC) and a pharmaceutically effective amount of triamcinolone hexacetonide (TAH). The composition is stable in an accelerated shelf life test in which the composition is heated to 80° C. for 24 hours.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: September 25, 2012
    Assignee: Genzyme Corporation
    Inventors: Grace Chang, Elizabeth Voschin, Li-Ping Yu, Eugene Skrabut
  • Stable Hyaluronan/Steroid Formulation
    Publication number: 20110059918
    Abstract: A pharmaceutical composition comprising in admixture a hyaluronic acid related component (HARC) and a pharmaceutically effective amount of triamcinolone hexacetonide (TAH). The composition is stable in an accelerated shelf life test in which the composition is heated to 80° C. for 24 hours.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 10, 2011
    Inventors: Grace Chang, Elizabeth Voschin, Li-Ping Yu, Eugene Skrabut